Skip to content

Single Session Intervention for Building Self-Compassion Habits-RCT

A Single Session Intervention Leveraging an Ultra-Brief Exercise for Building Self-Compassion Habits-A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05199779
Enrollment
135
Registered
2022-01-20
Start date
2022-02-13
Completion date
2022-04-29
Last updated
2022-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transdiagnostic Psychopathology

Keywords

Self-Compassion, Habits, Transdiagnostic, Intervention

Brief summary

The study will test a single session self-compassion intervention that leverages an ultra-brief contemplative exercise. It will evaluate the effect of this intervention on psychopathology, stress, growth mindset, positive affect, self-compassion and the automaticity of self-compassion, as well as the relationships between these constructs and the automaticity of self-compassion. The participants will be undergraduate students at a large public university.

Detailed description

The broad aims of the proposed research is to examine the outcomes of a single session psychological intervention and to further understand processes and factors associated with habit formation. undergraduate students at a large university will be randomly assigned to a self-compassion intervention (SCI), or an active control (AC), and complete assessments at baseline (pre-treatment) and 4 weeks later (post-treatment). The investigators seek to examine the following: (A1) Determine whether the group who receives the SCI, relative to the AC, will experience increased self-compassion, growth mindset and positive affect, as well as reduced stress and psychopathology. (A2) Evaluate whether the SCI group shows greater increases in automaticity of self-compassion compared to the AC pre- to post-treatment. (A3) Assess whether greater pre- to post-treatment increases in automaticity of self-compassionate are associated with increased self-compassion, growth mindset, and positive affect, as well as reductions in stress and psychopathology. The investigators hypothesize the following: (H1) SCI will promote greater increases in self-compassion, growth mindset, and positive affect, as well as greater reductions in stress and psychopathology from pre- to post-treatment, relative to AC. (H2) The SCI group will show greater increases in the automaticity of self-compassion than AC from pre- to post-treatment. (H3) Greater increases in the automaticity of self-compassion from pre- to post-treatment will be predicted by greater increases in self-compassion, growth mindset, and positive affect, as well as greater decreases in psychopathology and stress, from pre- to post treatment. To further understand the results obtained, the investigators will evaluate participants' frequency, adherence, and impressions of using the intervention.

Interventions

BEHAVIORALSingle Session Intervention Leveraging an Ultra-Brief Self-Compassion Exercise

This 20-second contemplative exercise includes draws from the science of habit formation and includes elements of self-soothing touch, somatic experiencing, and mindful self-compassion.

BEHAVIORALFinger-Tapping Active Control

This 20-second finger tapping exercise involves touching each finger to the thumb on one hand and repeating for twenty seconds. This intervention was designed to control for the potential effect of assessment on outcomes, the effect of having an activity to do for the duration of the intervention (4 weeks), regression to the mean, time, or other nonspecific factors.

Sponsors

University of California, Berkeley
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

To reduce bias in the assessments, none of the constructs of interest to this study (e.g., stress, self-compassion) will be included in the language used to describe the intervention or in any materials used to advertise the study. Study participants will be told they are participating in a study on fostering emotional well-being. No further information about the intervention will be provided.

Intervention model description

Participants will be randomized to the SCI or AC control using the randomizer elements in Qualtrics.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older. * English language proficiency. * Able and willing to give informed consent.

Exclusion criteria

* Does not have email address or access to email. * Not able/willing to participate in and/or complete the pre-treatment assessments

Design outcomes

Primary

MeasureTime frameDescription
DSM-5 Cross-Cutting Measure (DSM-XC)Change from baseline to post-treatment (week 4)22 items (suicidality item Q11 removed). 5-point scale (0=none or not at all; 1=slight or rare, less than a day or two; 2=mild or several days; 3=moderate or more than half the days; and 4=severe or nearly every day).
Kind of Person' Implicit Theory Scale (KOPITS)Change from baseline to post-treatment (week 4)8 items. 6-point response scale (1 = strongly agree; 6 = strongly disagree) Higher scores indicate a more growth mindset. Lower scores indicate a more fixed mindset. Score is sum of all items, with Q3, Q5, Q7, and Q8 reverse-scored. The formula for reverse-scoring an item is: ((Number of scale points) + 1) - (Respondent's answer)
Sussex-Oxford Compassion for the Self Scale (SOCS-S)Change from baseline to post-treatment (week 4)Sum of 20-item, 5-point response scale. Scores can range from 20 to 100 (Higher score means higher compassion for self). Sub-scale items included.
10-item Perceived-Stress Scale (PSS-10)Change from baseline to post-treatment (week 4)10 items, 5 point response scale (from 0 = Never to 4 = Very Often) Scoring: Reverse score (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) items 4, 5, 7, & 8 and then summing across all scale items.
Positive and Negative Affect Schedule (PANAS)Change from baseline to post-treatment (week 4)10 items with a 6 point response scale. Positive affect sub-scale only. Scoring: Positive Affect Score: Sum score of 1, 3, 5, 9, 10, 12, 14, 16, 17, and 19. Scores range from 10 - 50. Higher scores = higher levels of positive affect. Negative Affect Score: Sum score of 2, 4, 6, 7, 8, 11, 13, 15, 18, and 20. Scores range from 10 - 50. Lower scores = lower levels of negative affect.
Self-Report Behavioral Automaticity Index for Self-CompassionChange from baseline to post-treatment (week 4)20 items. 1-9 scale.

Secondary

MeasureTime frameDescription
Real Self Overlap ScaleChange from baseline to post-treatment (week 4)1 item. 1-8 scale.
State Self-Compassion Scale Long Form (SSCS-L)Change from pre-induction to post-induction at baseline and at post-treatment (week 4). Change in pre to post-induction changes in state self-compassion from baseline to post-treatment (week 4)9 items. 1-5 scale. Scores range from 9-45. Mindfulness, common humanity, and self-kindness sub-scales only.
Self-Report Behavioral Automaticity Index for ExerciseChange from baseline to post-treatment (week 4)4 items. 1-9 scale.

Other

MeasureTime frameDescription
Practice FrequencyAssessed at Post-treatment (week 4)Number of times practiced self-compassion exercise per day. 1 item.
General impressions of exerciseAssessed at Post-treatment (week 4)Exploratory qualitative assessment.
Adherence Report ScaleAssessed at Post-treatment (week 4)10 items on a five-point scale, where 5 = never, 4 = rarely, 3 = sometimes, 2 = often and 1 = always. Scores for each item were summed to give a total score, with higher scores indicating higher levels of reported adherence.
Practice DurationAssessed at Post-treatment (week 4)1 item, number of days practiced exercise but for less than 10 seconds.
Overall Practice FrequencyAssessed at Post-treatment (week 4)Number of days in the past two months that did not practice the exercise at all. 1 item.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026